1416334-69-4
GSK-A1
281224-40-6
M-31850
81845-98-9
Treprostinil methyl ester
101692-03-9
Treprostinil impurity
2864383-32-2
Ethyl (2R,3R)-3-cyclopropyl-1-methylaziridine-2-carboxylate
475086-28-3
Selexipag impurity
1355990-07-6
Treprostinil ethyl ester
2641824-60-2
(S)-Methyl (S)-3-(4-((tert-butoxycarbonyl)morpholin-2-yl)-2-((benzyloxycarbonyl)amino)propanoate
2762619-63-4
BPI-460372
325694-03-9
WAY-313356
1402057-86-6
Cdc7-IN-5
791840-86-3
NLRP3/AIM2-IN-2
2991059-69-7
Letermovir impurity 13
2238819-65-1
NLRP3-IN-19
2309409-79-6
CMP-5 hydrochloride
1380593-17-8
ST1237
433212-75-0
SSAA09E1
2791472-12-1
AZD2389
1809170-59-9
UniPR1331
3026691-12-0
10-(6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl)-4,7,13,16-tetraoxa-10-azanonadecane-1,19-dioic acid
More Information:
Check CAS No 2991059-69-7 on External Site
2991059-69-7
letermovir,impurity,2991059-69-7
2025-12-24 Discover Letermovir impurity 13 (CAS No: 2991059-69-7) and related compounds. Ideal for advanced chemical applications. Competitive pricing, fast delivery, and expert support worldwide.